GSK shares kept at neutral by Citi as unproven phase III pipeline curbs long-term growthProactive Investors • 08/20/26
Trump wants to split the MMR vaccine. Experts say that's unlikely — and comes with consequencesCNBC • 08/11/26
Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in USReuters • 07/30/26
GSK Beats Q2 Earnings & Revenue Estimates, Announces Cost-Saving PlanZacks Investment Research • 07/29/26
GSK beats second-quarter profit estimates, launches $2.52 billion cost savings driveReuters • 07/28/26
Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancerPRNewsWire • 07/22/26
GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 07/21/26
ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026Business Wire • 07/21/26
GSK Discontinues Development of Camlipixant for Refractory Chronic CoughZacks Investment Research • 07/17/26